The name of the treatment contains in a single word the application area (the neck, “Modì” was the nickname of Tuscan painter, Amedeo Modigliani, who portrayed female subjects with very long, slim necks) and “Lite”, which on one hand refers to the lightweight and micro-invasiveness of the treatment, and on the other, the therapeutic source (Light, therefore Laser).
The name ModìLite allows for differentiating the procedure performed with ECHOLASER (micro-invasiveness and multi-fibre approach in a single system) from the other thermal ablation techniques.

When ModiLite is used?

ModìLite is indicated for those who have one or more benign solid thyroid nodules which are large enough to create aesthetic damage or local compression symptoms, or for those who prefer not to undergo surgery.
ModìLite is also a safe and effective treatment for subjects who, due to critical medical conditions, are not able to undergo surgery.
Despite focusing on treatment of benign solid thyroid nodules, Modìlite is also effective for malignant neck lesions such as metastatic lymph nodes. With this application, the treatment is radical, obtaining complete ablation of the lesion.

ModiLite features

Modìlite consists of the percutaneous insertion of optical fibres (1 or 2 depending on the size of the nodule), and the delivery of laser energy for several minutes which causes the heating of the tissues until they are destroyed. Subsequently, the progressive reduction of the volume of the thyroid nodule (reduction of at least > 50% compared to the basal volume at the one-year follow-up) induced by the natural reduction mechanisms of the necrotic tissues of the human body leads to the disappearance of the compressive symptoms and aesthetic damage to the neck.
The planning of the treatment, the insertion of the needles and the monitoring are all carried out under ultrasound guidance. In order to facilitate the insertion manoeuvre and plan the best positioning of the needles in the lesion, ECHOLASER exploits:

• Planning Software in the ultrasound unit that allows for choosing among the various treatment possibilities, the most suitable and safest for each specific case, and for controlling the correct positioning of the needles inside the nodule.
• Dedicated multi-applicator Guiding Systems for ultrasound probes specifically designed for the anatomical area of the thyroid, with the relative Biopsy Software that displays the guidelines on the screen;
  

ModiLite advanatges

• a reduction in the compressive symptoms and/or aesthetic damage
• “in situ” thermal destruction with a consequent reduction of the nodule volume
• preservation of the healthy tissue and the organ function
• highly predictable and repeatable coagulation volume, as required in the small organs
• use of fine, a-traumatic needles for the neck structures
• possibility of treating patients with pace-makers (excellent electromagnetic compatibility)
• absence of general anaesthesia (thanks to the very fine needles not even local anaesthetic is necessary)
• short duration of the treatment (few minutes)
• absence of scars on the neck
• rapid recovery times
• life-long hormone replacement therapy not necessary
• no or insignificant post-treatment pain

The name of the treatment contains in a single word the application area (the liver, “PB” is the abbreviation of Prometheus bound, the titan who in Greek mythology was condemned to be bound to the rocks of the Caucasus while an eagle pecked at his liver each day) and “Lite”, which on one hand refers to the lightweight and micro-invasiveness of the treatment, and on the other, the therapeutic source (Light, therefore Laser).
The name PBLite allows for differentiating the procedure with ECHOLASER (micro-invasiveness and multi-fibre approach in a single system) from the other thermal ablation techniques.

When PBLite is used?

PBLite is indicated in the treatment of primitive and secondary liver cancer in the form of focal lesions.
 PBLite is also a safe and effective treatment of those who, due to critical medical conditions, are not able to undergo surgery.

PBLite features

PBLite consists of the percutaneous insertion of optical fibres (from 1 to 4 depending on the size of the tumour), and the delivery of laser energy for several minutes which causes the heating of the tissues until they are completely destroyed with a sufficient safety margin. The positioning of the applicators, monitoring of the treatment and verification of the effective coagulation area are all carried out under ultrasound guidance.
In order to facilitate the insertion manoeuvre, the system has dedicated multi-applicator Guiding Systems for ultrasound probes designed for the anatomical area of the liver with relative Biopsy Software that displays the guidelines on the screen.
As these are malignant tumours, the objective of the treatment is complete ablation of the lesion and subsequent absence of post-treatment local relapses and a net increase in the long-term survival probabilities (5 years).

PBLite advanatges

• a complete ablation with a sufficient safety margin
•  “in situ” thermal destruction
• a preservation of the healthy tissue and the organ function
• highly predictable and repeatable coagulation volume as required for the safety margin
• localized thermal effect in the target volume only, which makes the treatment possible close to sites at risk
• use of fine, a-traumatic needles for liver organ
• possibility of treating patients with pace-makers (excellent electromagnetic compatibility)
• absence of general anesthesia
• short duration of the treatment (few minutes)
• rapid recovery times
• no or insignificant post-treatment pain
• brief hospitalization
• bridging therapy for organ transplants

The name of the treatment contains in a single word a connection with urologic application (“Soracte” is the name of an Italian mountain (also named in the incipit of an Horace Poem),  where there was a monastery in which the monk Nonnoso, canonized, is considered the protector of people with kidney disease) and “Lite”, which on one hand refers to the lightweight and micro-invasiveness of the treatment, and on the other, the therapeutic source (Light, therefore Laser).
The name SORACTELite allows for differentiating the procedure with ECHOLASER (micro-invasiveness and multi-fibre approach in a single system) from the other thermal ablation techniques

When SORACTELite is used?

SORACTELite is indicated in the case of patients suffering from Benign Prostatic Hyperplasia, a disease in which the volumetric increase in the prostate gland generates a compression effect at the level of the bladder floor and the urethral canal, and also in the case of subjects who choose not to undergo surgical treatment.
When you hear the word laser in urology, you instantly may think of surgical lasers, like the green laser. These lasers are an important advancement for endoscopic, transurethral surgery of the prostate. However, SORACTELite has got nothing to do with surgical lasers; in fact, it differs in:
wavelength and power (our laser is not visible as opposed to green),

• its mode of action (cytoreduction vs surgical vaporization), and lastly and most importantly
• SORACTELite is performed in a truly microinvasive approach (transperineal vs transurethral).
  

SORACTELite represents true innovation for BPH treatment.

Despite focusing mainly on the treatment of Benign Prostatic Hyperplasia (BPH), SORACTELite is also effective for prostate cancer that is not clinically relevant combined with active surveillance and post-prostatectomy relapse and for kidney cancer.

SORACTELite features

SORACTELit  treatment consists of the percutaneous insertion of optical fibres (one or two fibres per lobe depending on the basal volume of the prostatic gland) via transperineal access, and the delivery of laser energy for several minutes which causes the heating of the tissues until they are destroyed, followed by a progressive reduction in the volume of the prostatic lobe (a reduction of at least 40% compared to the basal volume at the one-year follow-up) and subsequent disappearance of the symptoms. The planning of the treatment, the insertion of the needles and the monitoring are all carried out under ultrasound guidance. In order to facilitate the insertion manoeuvre, the system has a dedicated multi-applicator Guiding System for transrectal ultrasound probe with relative Biopsy Software that displays the guidelines on the screen.

SORACTELite advantages

•  resolution of symptoms
• “in situ” thermal damage with consequent reduction of the prostatic lobe
• preservation of the healthy tissue and the organ function
• highly predictable and repeatable coagulation volume
• use of fine, a-traumatic needles with transperineal approach
• absence of general anaesthesia
• short duration of the treatment (few minutes)
• rapid recovery times
• no or insignificant post-treatment pain
• absence of erectile dysfunction or complications linked to the reproductive organs